Group CEO and Founder

Cycle Pharmaceuticals Signs Exclusive U.S. Sales License for PHYRAGO™ (dasatinib) Tablets

Cycle Pharmaceuticals launches HARLIKU™ (nitisinone) Tablets, the first FDA-approved treatment for use in Alkaptonuria (AKU)

Pledging ‘Radical Transparency,’ FDA Reveals Drug Rejection Letters — With Limits

FDA nod for Cycle Pharma’s Harliku for alkaptonuria

Specialty Pharmacy Manager

Cycle Pharmaceuticals is a company focused on improving patient care in the pharmaceutical industry, particularly for rare diseases. They are seeking a Specialty Pharmacy Manager to lead impactful projects, manage pharmacy partnerships, and ensure compliance with high standards while driving contract excellence.

Sign up with Google

Sign in with Google